Verde Science, Inc.

Equities

VRCI

US92337L2034

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 11:40:42 22/03/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2021	Verde Science : Two more UK energy suppliers stop trading on gas price hit	RE
2018	Verde Science, Inc. Announces Executive Changes	CI

Rango Energy, Inc. and Innex Energy Announce to Create New Company; Appoints Robert Harrell as the Head of the New Company

April 02, 2014 at 12:11 am IST

Rango Energy Inc. announced that it has agreed to divest its current joint venture agreement with Innex Energy to a new company.

The company will be headed by Robert Harrell. Rango Energy will be providing information to its shareholders about new business initiatives away from the oil and gas industry. Mr. Harrell has agreed to step down from Rango as its CEO and Chairman.

Latest news about Verde Science, Inc.

Verde Science : Two more UK energy suppliers stop trading on gas price hit	22/21/22	RE
Verde Science, Inc. Announces Executive Changes	29/18/29	CI
Verde Science, Inc. Announces Management Changes	31/18/31	CI
Verde Science, Inc. Announces Management Changes	06/17/06	CI
Verde Science, Inc. Announces Plan to Study Cannabis Preparation for Treatment of Huntingdon's Disease	09/15/09	CI
Verde Science, Inc. Announces Board Changes	19/15/19	CI
Verde Science, Inc. Appoints Harpreet Sangha as Interim Chief Financial Officer	01/15/01	CI
Verde Science Appoints Bradley J. Dixon and John Percival to Board of Directors	27/15/27	CI
Verde Science, Inc. Appoints David Alexander as Chief Financial Officer	27/15/27	CI
Verde Science, Inc. Auditor Raises 'Going Concern' Doubt	20/15/20	CI
Verde Science, Inc. will Change its Ticker to VRCI from VRCI.D	11/15/11	CI
Verde Science, Inc. will Change its Ticker to VRCI.D from VRCI	14/15/14	CI
Rango Energy Inc. cancelled the acquisition of INNEX Energy, L.L.C.	02/14/02	CI
ID Global Corporation Signs a Binding Memorandum of Understanding with Verde Science, Inc	01/14/01	CI
Verde Science, Inc. Announces Research and Development Alliance with an Indian Pharmaceutical Company	23/14/23	CI
Hangtown Energy Inc. cancelled the acquisition of Rango Energy Inc. in a reverse merger transaction.	15/14/15	CI
Verde Science, Inc. announced that it has received $0.8 million in funding.	27/14/27	CI
Verde Science, Inc. Appoints Bradley J. Dixon, J.D. to the Board of Directors	19/14/19	CI
Verde Science, Inc. Appoints Ken Berscht to the Position of CEO	16/14/16	CI
Verde Science, Inc. Signs First Long Term Advisory Services Contract with Los Angeles County Medical Marijuana Dispensary	02/14/02	CI
Verde Science, Inc. announced that it expects to receive $0.30 million in funding.	28/14/28	CI
Verde Science, Inc. Announces the Appointment of Paul Pelosi to its Advisory Board	22/14/22	CI
Rango Energy Inc. cancelled the acquisition of 75% stake in 6,000 acres located in the Ft. Worth Basin from Proco Operating Co. Inc.	15/14/15	CI
Verde Science, Inc. Appoints Luis Bobadilla III as its Board Directors	14/14/14	CI
Rango Energy Inc. has Changed its Name to Verde Science, Inc	07/14/07	CI

Chart Verde Science, Inc.

Duration

Period

More charts

Company Profile

Verde Science, Inc. is a pharmaceutical research and development company. The Company is engaged in medical science consulting business. The Company is focused on the discovery of drugs and treatment modalities, as well as diagnostic devices and pharmaceutical delivery systems for the treatment of diseases and medical issues. The Company is focused on developing medicinal formulations from cannabinoids and tetrahydrocannabinol (THC) compounds for the treatment of various issues, such as migraines, glaucoma, loss of appetite from cancer therapies, and other medical issues. The Company is focused on launching its THC Pharmaceutical Development Program by executing a research program, which involves developing formulations preparing protocols for clinical trials.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERDE SCIENCE, INC.	-.--%	23
VERTEX PHARMACEUTICALS INCORPORATED	+18.66%	12TCr
REGENERON PHARMACEUTICALS, INC.	+14.84%	11TCr
BIONTECH SE	-3.85%	2.4TCr
ARGENX SE	+2.18%	2.26TCr
GENMAB A/S	-10.09%	1.82TCr
WUXI APPTEC CO., LTD.	-41.04%	1.68TCr
BEIGENE, LTD.	-12.04%	1.62TCr
NEUROCRINE BIOSCIENCES, INC.	+2.04%	1.34TCr
SAREPTA THERAPEUTICS, INC.	+24.62%	1.13TCr

Bio Therapeutic Drugs